1. One-carbon metabolism for cancer diagnostic and therapeutic approaches
   Ayumu Asai et al, 2020, Cancer Letters CrossRef
2. JARID1‐targeted histone H3 demethylase inhibitors exhibit anti‐proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines
   Savannah J. Tobin et al, 2021, Veterinary and Comparative Oncology CrossRef
3. Dissecting the functional pleiotropism of lysine demethylase 5B in physiology and pathology
   OluwaseunAdebayo Bamodu et al, 2020, Journal of Cancer Research and Practice CrossRef
4. Characterizing isoform switching events in esophageal adenocarcinoma
   Yun Zhang et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
5. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
   LIPING FANG et al, 2016, International Journal of Molecular Medicine CrossRef
6. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
   Yi-Chao Zheng et al, 2019, European Journal of Medicinal Chemistry CrossRef
7. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
   Lishuang Wang et al, 2015, Tumor Biology CrossRef
8. Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates
   Hanna Tarhonskaya et al, 2017, Journal of Molecular Biology CrossRef
9. The Truth Behind Esophagus: The Stem Cells’ Significance
   Maximos Frountzas et al, 2019, Digestive System Diseases CrossRef
10. Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus
    YOSHIHIRO KANO et al, 2014, Oncology Reports CrossRef
11. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review)
    Masamitsu Konno et al, 2017, International Journal of Oncology CrossRef
12. Jumonji AT‑rich interactive domain 1B promotes the growth of pancreatic tumors via the phosphatase and tensin homolog/protein kinase B signaling pathway
    Xudong Shen et al, 2018, Oncology Letters CrossRef
13. Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
    Anmi Jose et al, 2020, Cancers CrossRef
14. Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance
    Yaquan Cao et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
15. Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase/AKT pathway
    Yaquan Cao et al, 2023, European Journal of Medicinal Chemistry CrossRef
16. Histone Peptide Recognition by KDM5B-PHD1: A Case Study
    Suvobrata Chakravarty et al, 2015, Biochemistry CrossRef
17. Histone demethylase lysine demethylase 5B in development and cancer
    Mengjiao Han et al, 2017, Oncotarget CrossRef
18. Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine
    Kelly A. Whelan et al, 2018, Cellular and Molecular Gastroenterology and Hepatology CrossRef
19. One-Carbon and Polyamine Metabolism as Cancer Therapy Targets
    Anowarul Islam et al, 2022, Biomolecules CrossRef
20. Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways
    Zhiliang Jin et al, 2016, Oncology Letters CrossRef
21. Targeting histone demethylase KDM5B for cancer treatment
    Yun-Dong Fu et al, 2020, European Journal of Medicinal Chemistry CrossRef
22. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
    Bo Tang et al, 2015, Oncotarget CrossRef
23. Critical roles of non-histone protein lysine methylation in human tumorigenesis
    Ryuji Hamamoto et al, 2015, Nature Reviews Cancer CrossRef